首页> 外文期刊>Endocrine >SIRT1 prevents hyperuricemia via the PGC-1 alpha/PPAR gamma-ABCG2 pathway
【24h】

SIRT1 prevents hyperuricemia via the PGC-1 alpha/PPAR gamma-ABCG2 pathway

机译:SIRT1 prevents hyperuricemia via the PGC-1 alpha/PPAR gamma-ABCG2 pathway

获取原文
获取原文并翻译 | 示例
           

摘要

Silent information regulator T1 (SIRT1) plays several key roles in the regulation of lipid and glucose homoeostasis. In this study, we investigated the potential role of SIRT1 in hyperuricemia and explored possible mechanisms. Significant hyperuricemia was detected in C57BL/6 mice treated with oxonate and yeast polysaccharide. Resveratrol (RSV), a specific SIRT1 activator, was administered to the mice. SIRT1 suppressed the increased serum uric acid level but up-regulated the expression of urate transporter ATP-binding cassette subfamily G member 2 (ABCG2) in the ileum of hyperuricemic mice. In a human colon carcinoma cell line, SIRT1 promoted ABCG2 production through the deacetylation of peroxisome proliferator-activated receptor (PPAR) gamma co-activator 1 alpha (PGC-1 alpha), which then activated the effectors of PPAR gamma. Interestingly, the SIRT1-induced up-regulation of ABCG2 was significantly inhibited when PGC-1 alpha or PPAR gamma was blocked by siRNA transfection. Our data demonstrated that SIRT1 and its activator, RSV, have clear anti-hyperuricemia functions in this mouse model. One possible mechanism is the activation of ABCG2 in the ileum through the PGC-1 alpha/PPAR gamma pathway.

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号